Steris | STE - Loan Capital


Steris reported $1.81B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
3M USD 10.9B 2M Jun/2026
Accuray USD 124.78M 2.54M Dec/2025
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 10.86B 148M Mar/2026
CONMED USD 657.05M 203.11M Jun/2026
Cooper Companies USD 1.86B 17.7M Mar/2026
Dexcom USD 1.3B 200K Jun/2026
Ecolab USD 11.91B 4.98B Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Fortive USD 3.51B 920M Jun/2026
Getinge SEK 9.09B 167M Jun/2026
Globus Medical USD 398K 38K Mar/2026
Haemonetics USD 1.22B 299.58M Mar/2026
Idexx Laboratories USD 299.86M 11K Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.34B 183M Jun/2026
Olympus JPY 159.7B 61M Mar/2026
Orthofix International USD 221.59M 256K Jun/2026
Owens Minor USD 1.8B 35.38M Dec/2025
ResMed USD 404.17M 245K Mar/2026
Steris USD 1.81B 85.6M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 601.77M 291.73M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026